DuPont de Nemours, Inc.
DuPont de Nemours, Inc. (DD)
Overview
DuPont de Nemours, Inc. is a specialty materials and solutions company headquartered in Wilmington, Delaware, and a longstanding member of the S&P 500. Descended from a gunpowder manufacturer founded in 1802 by Éleuthère Irénée du Pont, the modern DuPont is the product of a dramatic multi-year corporate reshaping: a 2017 mega-merger with Dow Chemical to form DowDuPont, followed by a 2019 three-way separation into Dow (materials science), Corteva (agriculture), and a re-formed DuPont focused on specialty products, and then a further split in November 2025 that spun off its electronics materials business as the independent company Qnity Electronics. Following that spinoff and the 2025 sale of its Aramids business (Kevlar/Nomex) to Arclin, DuPont today is a smaller, more focused company with roughly $6.8–7.0 billion in annual revenue, about 15,000 employees worldwide, and a market capitalization in the high-teens of billions of dollars — a fraction of its size just a few years ago, reflecting the deliberate strategy of separating distinct businesses into standalone public companies.
What They Do & How They Make Money
DuPont makes money by developing, manufacturing, and selling advanced engineered materials, chemicals, and components that other manufacturers and institutions build into their own products or use in their operations — it is a business-to-business specialty materials company, not a consumer brand, even though several of its product names (Tyvek, Corian, Styrofoam) are widely recognized. Revenue comes from selling proprietary, technically differentiated materials — protective fabrics, water-treatment membranes and resins, engineered polymers, and industrial components — at premium prices justified by performance characteristics (durability, purity, chemical resistance, filtration efficiency) that customers can't easily substitute with generic alternatives. The company invests heavily in materials science R&D and in application-specific engineering support for customers, which helps it embed its products into customers' designs and manufacturing processes, creating recurring, specification-driven demand rather than one-off commodity sales. Growth is pursued both organically (new product formulations, capacity expansion in categories like water filtration and lithium extraction materials) and through portfolio actions — DuPont has repeatedly bought, sold, and spun off entire business lines (Nutrition & Biosciences to IFF in 2021, Delrin acetal business, the Qnity electronics spinoff, and the Aramids divestiture) to concentrate capital and management attention on the segments where it believes it has the strongest competitive position and growth prospects.
Business Segments
Following the November 2025 Qnity Electronics spinoff, DuPont now reports its results across two primary segments:
- Healthcare & Water Technologies: Includes specialty materials for medical devices and pharmaceutical packaging, protective apparel and materials sold under the Tyvek brand (used in healthcare, cleanroom, and personal-protection applications), and a substantial water-technologies business — ion-exchange resins (Amberlite), reverse-osmosis and filtration membranes (FilmTec), and related systems serving industrial wastewater treatment, desalination, power generation, municipal water, and life-sciences customers. Water technologies in particular has been highlighted by management as a long-term secular growth driver given global water-scarcity and reuse trends.
- Diversified Industrials: Covers engineered materials and components for construction (Tyvek weather/house wrap, Styrofoam insulation, Corian solid-surface products), and engineered polymer and specialty components serving automotive, aerospace, semiconductor-adjacent, printing, and packaging markets (Vespel high-performance parts, Molykote specialty lubricants, Cyrel flexographic printing plates).
Because the Qnity separation only closed in late 2025, DuPont's reported historical financials (including full-year 2024 and prior) still reflect the larger, pre-spinoff company that included the Electronics & Communications, Industrial Biosciences, and Safety & Protection segment structure; the two-segment Healthcare & Water Technologies / Diversified Industrials structure reflects the company's current, smaller post-separation footprint. DuPont has not disclosed a detailed revenue split between the two current segments in the sources reviewed, though both are described as roughly comparable-scale, diversified businesses within the smaller post-spinoff company.
Competitors
- Specialty chemicals and materials companies: Celanese, Eastman Chemical, Honeywell (Advanced Materials), 3M, Ashland, Avient, and PPG Industries compete across various engineered-materials and specialty-chemical product lines.
- Water technology and filtration: Ecolab, Veolia, Xylem, Danaher (via its water-quality businesses), and Evoqua (now part of Xylem) compete directly with DuPont's water-treatment resins, membranes, and systems.
- Protective materials and building products: Berry Global, Kimberly-Clark, and various nonwovens producers compete with Tyvek in protective-apparel applications, while building-products competitors (Owens Corning, CertainTeed) compete in insulation and house-wrap categories.
- Sibling/former-affiliate companies: Dow Inc., Corteva, and Qnity Electronics — all spun out of the former DowDuPont — are no longer part of DuPont but remain useful comparators for investors evaluating the broader "DowDuPont breakup" thesis, and Qnity in particular now competes for capital and talent in adjacent advanced-materials markets.
Competitive Position
DuPont's competitive advantage rests on decades of accumulated materials-science intellectual property, proprietary manufacturing know-how, and strong brand recognition in specific technical niches (Tyvek in protective materials and house wrap, FilmTec and Amberlite in water treatment) that create real switching costs for industrial and institutional customers who have qualified DuPont materials into their own regulated or engineered product designs. The post-2025 portfolio, concentrated in healthcare/water technologies and diversified industrials, is explicitly designed by management to focus capital and R&D on categories with durable secular demand growth — particularly water scarcity/treatment and healthcare packaging — while shedding businesses (electronics, aramids) deemed better suited to standalone ownership or better strategic fits elsewhere. This continuous portfolio reshaping is itself both a strength (capital discipline, focus, and repeated value-realization through spinoffs and divestitures) and a risk: the frequent restructuring makes historical financial comparisons difficult, creates execution and integration risk with each transaction, and has substantially shrunk the company's revenue base, raising questions about the durability of growth in the smaller remaining businesses. Other key risks include cyclicality tied to construction, automotive, and industrial end-markets; input-cost and raw-material price volatility; litigation and remediation liabilities related to historical chemical manufacturing (including PFAS-related legal exposure, some of which was structurally addressed via a cost-sharing agreement among DuPont, Chemours, and Corteva); and competitive pressure from larger, more diversified chemical companies that can undercut on price in less-differentiated product lines. DuPont's ability to sustain premium pricing depends on continued innovation and customer qualification cycles, making R&D investment and application-engineering support central to defending its market position.